News
Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics
Read more
Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics
Read more
Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
Read more
Shift Bioscience establishes North American facilities to expand capabilities of AI-powered virtual cell technology
Read more
Daniel Ives talks to AWS about the AI virtual cell and its key role in discovery of rejuvenation biology
Read more
Lucas Camillo and Bo Wang release CpGPT, a foundation model for DNA methylation
Read more
Shift Bioscience raises $16M to advance AI virtual cell platform for cell rejuvenation
Read more
Guardian article on rejuvenation race mentions Shift Bioscience
Read more
Daniel Ives features in Cambridge University's Enterprising Minds
Read more
Daniel interviewed by Eleanor Sheekey
Read more
Nature Biotechnology features Shift Bioscience
Read more
Shift Bioscience at the Investing in the Age of Longevity conference in London
Read more